Safety Of Crisaborole In Patients Aged 3 To <24 Months With Mild-To-Moderate Atopic Dermatitis

Authors :: Julie S. Shepard
John C Su
Charles Lynde
Bonnie Vlahos
Chuanbo Zang
Richard G. Gower
Joel Schlessinger
John L. Werth
Liza Takiya
Daniela Graham
Amy Cha
Source :: Section on Advances in Therapeutics and Technology Program.
Publication Year :: 2021
Publisher :: American Academy of Pediatrics, 2021.

Subjects :: medicine.medical_specialty
business.industry
Crisaborole
Medicine
In patient
Atopic dermatitis
business
medicine.disease
Dermatology

Full Text Access

Tools